The Pirbright Institute

What The Pirbright Institute does

The Pirbright Institute is a UK-based, non-profit research institute founded in 1914 and headquartered in Pirbright, Woking. It operates as a world-leading centre of excellence for the research and surveillance of viral diseases affecting livestock (foot-and-mouth disease, African swine fever, avian influenza, Rift Valley fever, bluetongue) and zoonotic viruses that transmit from animals to humans. The institute holds WOAH and FAO Reference Laboratory designations for multiple high-consequence animal diseases, and serves as the UK National Reference Laboratory for foot-and-mouth disease. Its core technology infrastructure comprises high-containment BSL-3 and BSL-4 laboratories, the BBSRC National Virology Centre (Plowright Building), the BBSRC National Vaccinology Centre (Jenner Building), the Biggs Avian Research Building, and unique animal models including the only UK facility permitted to test FMD in large animals.

The institute generates revenue primarily through government grants and core funding rather than commercial sales — BBSRC provides core national capability funding, supplemented by Defra, FCDO, the Bill & Melinda Gates Foundation, Innovate UK, and competitive research grants. Commercial revenue derives from licensing vaccine technologies (e.g., FMD vaccine licensed to MSD Animal Health) and fee-based services including diagnostic testing, disinfectant testing, and training courses in biosafety, science, and engineering. Distribution channels include the WOAH/FAO reference laboratory network, UK national reference laboratory services, vaccine technology licensing (notably to MSD Animal Health), and partnership-based vaccine development (e.g., GALVmed for low- and middle-income country deployment through CVIM). Customer segments span UK government veterinary authorities, international organizations (WOAH, FAO), vaccine development partners, academic research institutions, and human public health organizations pursuing One Health research.

The institute's product surface is anchored by the World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD), diagnostic testing services, disinfectant testing, training programs, and an expanding vaccine development portfolio operated through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM). Strategic positioning combines exclusive regulatory designations, irreplaceable physical infrastructure, decades of accumulated viral and animal line collections, and globally recognized scientific talent (including a 2026 WOAH Gold Medal recipient and a Fellow of the Royal Society), creating durable barriers to entry in livestock viral disease research and reference laboratory services.

Name

The Pirbright Institute

Legal name

The Pirbright Institute

Website

https://pirbright.ac.uk

Company type

Private

Founded year

1914

Operating status

Operating

Headcount range

251–500 employees

Short description

The Pirbright Institute is a UK non-profit research institute that prevents and controls viral diseases in livestock and zoonoses, operating WOAH/FAO reference laboratories and developing vaccines for diseases like foot-and-mouth disease, African swine fever, and avian influenza.

Ownership category

akta.pro rank

Product category

Veterinary Research & Reference Laboratory Services

NAICS

Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM)

akta.pro secondary industries

Veterinary Public Health Laboratories (Reference & Confirmatory) (HLAMAJAH), Zoonotic Disease Control & Risk Assessment (HLAMAJAE), Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC)

Keywords

• Viral disease research
• Livestock health
• Vaccine development
• Reference laboratory services
• Veterinary diagnostics

Headquarters

HQ city

Woking

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain

Distribution channels4 records

Marketing channels6 records

Core offering

The Pirbright Institute is a UK-based non-profit scientific research organization dedicated to the prevention and control of viral diseases of livestock and those that can spread from animals to humans. It operates as the FAO World Reference Laboratory for foot-and-mouth disease and several other economically significant livestock viruses, providing diagnostic testing, disease surveillance, vaccine research and development, and reference laboratory services to government and international stakeholders.

Product overview

The Pirbright Institute is a world-leading research centre of excellence focused on the research and surveillance of viral diseases of livestock and viruses that spread from animals to humans (zoonoses). It operates as a unified research institute with national capability status, providing reference laboratory services, diagnostic testing, disinfectant testing, and expert training courses. The Institute's core products include the World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD), diagnostic testing services, disinfectant testing, and training in biosafety, engineering, and science. Through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), the Institute also advances vaccine development for priority livestock diseases including Rift Valley fever and African swine fever. The institute offers access to specialized high-containment facilities, advanced technology platforms, and viral/animal line collections.

Differentiator

Problem solved

Functional benefit

Brands

• Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM): A center at The Pirbright Institute focused on accelerating the development and manufacturing of veterinary vaccines for livestock diseases globally.
• World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD)

Products and services

• FAO World Reference Laboratory for Foot-and-Mouth Disease

Quantifiable outcome

• $1.3 billion annual economic benefits projected from novel FMD vaccine at 20% market penetration
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

19 partnerships are on record, tiered core.

• The Vaccine GroupcoreStrategic or Co-development Partner · 30 April 2026Partnership for African swine fever vaccine development. The Pirbright Institute collaborates with The Vaccine Group to develop vaccines targeting ASFV, contributing expertise in virology and vaccine evaluation.
• GALVmedcoreStrategic or Co-development Partner · 21 August 2025Partnership through Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) to develop and deploy a safer Rift Valley fever vaccine for use in low- and middle-income countries across Africa. GALVmed works with local manufacturing partners for technology transfer, safety and efficacy testing, and market authorisation.
• Diamond Light SourcecoreStrategic or Co-development PartnerCollaboration on novel virus-like particle vaccine against foot-and-mouth disease. Diamond Light Source provided advanced imaging capabilities for vaccine research. Projected to deliver $1.3 billion annual economic benefits.
• MSD Animal HealthcoreOEM/ Whitelabel/ Licensing PartnerVaccine technology licensing partner for foot-and-mouth disease vaccine. MSD Animal Health holds commercial licence for new FMD vaccine and is pursuing regulatory approvals. Also collaborating on VLP FMD vaccine regulatory process.
• University of CambridgecoreStrategic or Co-development PartnerResearch collaboration on bat coronavirus receptor binding studies. University of Cambridge researchers worked with Pirbright scientists to discover how CcCoV-KY43 can enter human cells.
• KEMRI-Wellcome Trust Research ProgrammecoreStrategic or Co-development PartnerResearch collaboration on bat coronavirus studies in Kenya. Testing for evidence of spillover into local human population.
• University of YorkcoreStrategic or Co-development PartnerAcademic research partner in international team discovering new coronavirus entry mechanisms into human cells.
• City University of Hong KongcoreStrategic or Co-development PartnerJoint development of first international guidelines for field evaluation and post-vaccination monitoring of African swine fever virus vaccines, produced for WOAH member countries.
• University of CopenhagencoreStrategic or Co-development PartnerLead partner in EU Partnership on Animal Health and Welfare (EUPAHW) project on Highly Pathogenic Avian Influenza. Three-year international research project on H5 subtype viruses.
• INRAE FrancecoreStrategic or Co-development PartnerEUPAHW project partner focusing on viral dynamics in production animals, wildlife, and companion animals with expertise in diagnostics and vaccine innovation.
• University of FreiburgcoreStrategic or Co-development PartnerEUPAHW project partner contributing expertise in influenza virology and vaccine research.
• CPI (Centre for Process Innovation)coreTechnology or IntegrationPartnership with CVIM to advance RNA vaccine platforms for livestock. Initial focus on mRNA and saRNA vaccine development for veterinary applications.
• Quantoom BiosciencescoreTechnology or IntegrationPartnership with CVIM to advance mRNA and saRNA vaccine development for livestock diseases.
• ScitechcoreImplementation/ SI/ Consulting PartnerSpecialist in pharmaceutical design, engineering, construction and qualification. Partnered with Pirbright to build and deliver the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM).
• Chinese Academy of Agricultural Sciences (CAAS)coreStrategic or Co-development PartnerMemorandum of Understanding to build on existing collaborations with China's national agricultural research institutes and universities. Initial focus on avian diseases affecting poultry industry in UK and China.
• National Institute of Animal Biotechnology (NIAB) IndiacoreStrategic or Co-development PartnerCo-signed MoU to create animal disease and zoonosis laboratory partnership with UK. Aims to strengthen collaborations in animal health research.
• VIDO (Vaccine and Infectious Disease Organization), University of SaskatchewancoreStrategic or Co-development PartnerMoU for expanded collaborations and training in vaccine manufacturing. Allows for knowledge sharing and joint development of veterinary vaccines.
• Imperial College LondoncoreStrategic or Co-development PartnerOne Health Vector-Borne Diseases Hub led by Imperial. £1.5m initiative funded by Defra and BBSRC to tackle diseases spread by insects, ticks and mites.
• UK Research Institutions ConsortiumcoreStrategic or Co-development PartnerCollaboration with Moredun Research Institute, The Roslin Institute, and Royal Veterinary College to develop novel laboratory-based models for studying animal health and disease.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• USDA-ARS National Animal Disease Center: U.S. Department of Agriculture's primary research facility for livestock viral diseases, including FMD and avian influenza reference work; the closest functional analogue to Pirbright as a government-backed reference laboratory and vaccine R&D center operating outside the UK.

Direct peers

• CSIRO Australian Centre for Disease Preparedness: Australia's high-containment BSL-3/4 livestock virology reference laboratory at Geelong; shares Pirbright's WOAH/FAO Reference Laboratory scope, exotic disease diagnostic mandate, and vaccine development role for FMD, avian influenza, and African swine fever.
• Friedrich-Loeffler-Institut (FLI): Germany's federal research institute for animal health, hosting multiple WOAH Reference Laboratories and operating high-containment facilities for livestock viral diseases; matches Pirbright's reference-lab portfolio and vaccine R&D capabilities and is a direct EUPAHW partner.
• Wageningen Bioveterinary Research (WBVR): Dutch national reference laboratory for notifiable livestock viruses including FMD and avian influenza; competes with Pirbright for European reference-lab designations and operates similarly high-containment diagnostic infrastructure.
• VIDO (Vaccine and Infectious Disease Organization): University of Saskatchewan's vaccine R&D centre with Containment Level 3 capabilities for livestock infectious diseases; operates as both a research and contract vaccine manufacturing organization under an active MoU with Pirbright, making it a strong collaborative peer.
• INRAE (Animal Health division): France's national research institute for agriculture, food and environment, with significant livestock virology capacity covering influenza diagnostics and vaccine innovation; an active EUPAHW partner alongside Pirbright.
• Animal and Plant Health Agency (APHA): UK government agency operating Weybridge laboratory as a sister institution to Pirbright; jointly delivers statutory livestock disease diagnostics and surveillance in the UK and shares ex-APHA staff such as Ian Brown with Pirbright's leadership team.

Regional players

• Istituto Zooprofilattico Sperimentale (IZS) network: Italy's network of government veterinary institutes performing animal disease diagnostics, vaccine evaluation, and reference lab services; comparable peer primarily serving southern Europe with overlapping WOAH reference-lab functions for several of Pirbright's priority diseases.

Emerging players

• National Veterinary Institute (SVA, Sweden): Swedish national veterinary institute providing diagnostic services and applied research on livestock viral diseases; a smaller, geographically narrower peer that nonetheless competes for northern European reference-lab work on avian influenza and FMD.
• National Center for Foreign Animal and Zoonotic Disease Defense (FAZD Center): U.S. Department of Homeland Security Center of Excellence led by Texas A&M addressing foreign animal disease threats; a peer in livestock and zoonotic disease preparedness, though it focuses more on training and modeling than on operating a containment-laboratory reference service.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pirbright_inst
• Facebookfacebook.com/ThePirbrightInstitute
• LinkedInlinkedin.com/company/the-pirbright-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Pirbright Institute